Possible protective mechanisms of heme oxygenase-1 in the brain. 2002

K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
Department of Neurobiology, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8412, Japan.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006419 Heme Oxygenase (Decyclizing) A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. Haem Oxygenase,Heme Oxygenase,Oxygenase, Haem,Oxygenase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D017628 Microglia The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling. Microglial Cell,Cell, Microglial,Microglial Cells,Microglias
D051547 Heme Oxygenase-1 A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN. Hemeoxygenase 1,Heme Oxygenase 1,Oxygenase-1, Heme
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
August 2003, Trends in immunology,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
January 2002, Wiener klinische Wochenschrift,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
December 2010, Central nervous system agents in medicinal chemistry,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
July 2019, International journal of molecular sciences,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
October 2004, Antioxidants & redox signaling,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
September 2016, Basic research in cardiology,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
January 2010, Annual review of pharmacology and toxicology,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
July 1999, Chest,
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
June 2011, Frontiers in bioscience (Landmark edition),
K Takata, and Y Kitamura, and J Kakimura, and K Shibagaki, and T Taniguchi, and P J Gebicke-Haerter, and M A Smith, and G Perry, and S Shimohama
March 2009, Clinical nephrology,
Copied contents to your clipboard!